Cabotegravir RIF 343

Interaction Color Code
Clinical Bottom Line
Do not coadminister: Reduced levels of CAB
Drug 1
Drug 1 dose
30 mg single dose
Drug 1 effect

Cmax decreased 6%, AUC decreased 59%, Cmin decreased 50%

Drug 2
Drug 2 dose
600 mg once daily
Drug 2 effect

Not studied

Clinical Effects

Potential decrease in antiretroviral efficacy

Management

Contraindicated. Use alternative agents.

Import ID
343